Dr. Roshanak T. Semnani is an Executive Director, overseeing Translational Research at Precigen, Inc. based in Maryland, USA. She has her Ph.D. in Immunology from the University of Chicago and was at NIH prior to joining the company in 2018. She is an experienced multidisciplinary senior executive with extensive expertise in the field of infectious disease, autoimmunity, and immuno-oncology along with drug development in Cell and Gene therapy, from target identification/validation, preclinical Immunological studies, and clinical trials. Her experience involves combining basic and translational research for further understanding of the mechanisms of disease to develop strategies for which enable organizations to achieve their goals